Εμφάνιση απλής εγγραφής

dc.creatorSiskou O., Korompoki E., Ntaios G., Tsampalas E., Alexopoulou H., Kalliontzakis I., Kouridaki A., Tountopoulou A., Kouzi I., Vasilopoulou S., Milionis H., Evaggelou H., Karagkiozi E., Hatzitolios A.I., Savopoulos C., Myrou A., Manios E., Mavraganis G., Vemmou A., Kaitelidou D., Galanis P., Papastefanatos S., Konstantakopoulou O., Karagkouni I., Vemmos K.en
dc.date.accessioned2023-01-31T09:57:12Z
dc.date.available2023-01-31T09:57:12Z
dc.date.issued2020
dc.identifier10.3233/SHTI200585
dc.identifier.isbn9781643680927
dc.identifier.issn09269630
dc.identifier.urihttp://hdl.handle.net/11615/79057
dc.description.abstractThe aim of this study was to evaluate accessibility of stroke patients to optimal healthcare technology in Greece. Methods: The study population consisted of 313 first ever stroke patients derived from the 'Stroke Units Necessity for Patients, SUN4P' registry. Descriptive statistics were used, to present patients' characteristics and resources utilization Results: The vast majority of patients (91.7%) conducted a CT scan during the acute phase (within the first 24hours). Almost, (65%) were admitted to wards of Internal Medicine Departments, whereas only 21% of patients were admitted to a Stroke Unit. Of note, a total of 6.9% of ischemic stroke patients received intravenous thrombolytic therapy with recombinant tissue plasminogen activator (rtPA). Conclusions: Preliminary results from SUN4P underline the urgent necessity for the re-organization of acute stroke care in Greece, as rates of admissions to stroke units and rtPA treatment during the acute phase are currently below optimal. © 2020 The authors and IOS Press.en
dc.language.isoenen
dc.sourceStudies in Health Technology and Informaticsen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85087432766&doi=10.3233%2fSHTI200585&partnerID=40&md5=b724f6e52624e0bcb824a51cb43e500c
dc.subjectComputerized tomographyen
dc.subjectDrug therapyen
dc.subjectMedicineen
dc.subjectDescriptive statisticsen
dc.subjectHealthcare technologyen
dc.subjectInternal medicineen
dc.subjectIschemic strokesen
dc.subjectRecombinant tissue plasminogen activatorsen
dc.subjectResources utilizationsen
dc.subjectStroke patientsen
dc.subjectThrombolytic therapiesen
dc.subjectMedical informaticsen
dc.subjectfibrinolytic agenten
dc.subjecttissue plasminogen activatoren
dc.subjectadministrative personnelen
dc.subjectbrain ischemiaen
dc.subjectcerebrovascular accidenten
dc.subjectfibrinolytic therapyen
dc.subjectGreeceen
dc.subjecthumanen
dc.subjecttreatment outcomeen
dc.subjectAdministrative Personnelen
dc.subjectBrain Ischemiaen
dc.subjectFibrinolytic Agentsen
dc.subjectGreeceen
dc.subjectHumansen
dc.subjectStrokeen
dc.subjectThrombolytic Therapyen
dc.subjectTissue Plasminogen Activatoren
dc.subjectTreatment Outcomeen
dc.subjectIOS Pressen
dc.titleAccess of stroke patients' to optimal healthcare technology in Greece: Messages to policy makersen
dc.typeconferenceItemen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής